On the day after Mr. Dietlin's workshop, Tuesday, June 24, Mr. Tyson will conduct a workshop titled "Becoming a Sponsor of Choice for Clinical Investigators" from 8:00 am to 9:30 am. The workshop, which is part of the Clinical Trial Management/Clinical Supplies track, will discuss key factors driving investigators' choices of clinical study sponsors. It will also explore tactics for identifying a pharmaceutical or biotech company's strengths and weaknesses with respect to conducting clinical trials, as well as examine strategies for improving a company's relationship with the study sites and investigators it values most.
"It's critical that a pharmaceutical company do everything it can to be the study sponsor that sites prefer to work with -- the sponsor of choice -- because there are so many clinical trials that are competing for the same patients," Mr. Tyson said. "Companies will gain a clear advantage if they understand what's behind an investigator's or study site's decision to work with a particular sponsor," he said.
As the head of Campbell Alliance's Clinical Development Practice, Mr. Tyson leads a team that provides a range of operational improvement services to clinical development organizations within pharmaceutical and biotech companies, as well as at leading contract research organizations (CROs). He is a veteran of numerous electronic-data-capture-related initiatives, and brings a wealth of knowledge and experience in process improvement, organizational design, and clinical development to his consulting engagements.
|SOURCE Campbell Alliance|
Copyright©2008 PR Newswire.
All rights reserved